Medscape Conference Coverage, based on selected sessions at the:

American Public Health Association (APHA) 135th Annual Meeting and Exposition

November 3 - 7, 2007, Washington, DC

This activity is not sanctioned by, nor a part of, the American Public Health Association.

ALSO ON THIS PAGE:

Topic Overviews

  • CME/CE Emergent Issues in Public Health
    • Climate Change and Public Health
      Brian S. Schwartz, MD, MS
    • Public Health and Prevention: Late-Breaking Developments
      Cheryl E. Easley, PhD, RN; Carol Easley Allen, PhD, RN
    • HPV Vaccine: Ethics of a School Mandate
      Jennifer L. Young, MD, MPH
  • CME/CE Focus on Prevention
    • Innovative Technology: Increasing Access to Health Education
      Andrea Wershof Schwartz, BA, MA
    • Innovative Programs for Stopping Tobacco Abuse
      Laura J. Fish, PhD
    • Health Behavior Interventions
      Chudley (Chad) E. Werch, PhD
  • CME/CE Focus on Women's Health
    • Contraceptive Behavior and Risk Taking Among Adolescents
      Pat W. Mosena, PhD
    • Emergency Contraception: Effective Use
      Diana G. Foster, PhD
    • Women's Health in Midlife and Later Years: A New Generation of Research
      Marcia G. Ory, PhD, MPH

Conference News

  • Dating Violence Strikes Both Boys and GirlsBoth boys and girls experience physical violence within their dating relationships; a separate study addressed adult men who experienced sexual assault.
  • Multidrug-Resistant Tuberculosis Increasing in TexasAsymptomatic carriers of tuberculosis are the most difficult cases to diagnose; better diagnostic tools are needed, a researcher says.
  • APHA to Create Major Climate Change InitiativeThe American Public Health Association is meeting with public health experts and policy makers to develop a series of practical recommendations that the public can adopt to help reduce the health effects of climate change.
  • High Rate of PTSD in Returning Iraq War VeteransA minimum of 300,000 psychiatric casualties are expected to result among the veterans who have served in Iraq to date, with an estimated lifetime treatment cost of $660 billion.
  • Violent Death Associated With Specific HLA HaplotypesCertain heterozygotes for HLA-A and HLA-B heterozygotes were significantly associated with increased incidence of violent death; for HLA-BW, homozygotes had a significantly increased odds ratio, whereas heterozygotes had a significantly reduced odds ratio for violent death.

Legal Disclaimer

The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape and were developed in collaboration with the American Public Health Association.

Copyright © 2007 Medscape.


WebMD

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.